Insider Trends: Humanigen Insider Extends 90-Day Selling Trend
06:30 PM EST, 02/04/2021 (MT Newswires) -- Nomis Bay Ltd, 10% Owner, on Feb 02, 2021, sold 73,584 shares in Humanigen (HGEN) for $1,542,363. Nomis Bay, subsequent to the transactions detailed in the SEC Form 4 filing, owns 5,926,416 company shares, with a market value, based on the prior-day closing price, of $115 million.
In the 90 days previous to the date of this filing, there have been 8 transactions reported to the SEC, all of which have been sales and have resulted in the disposition of 495,133 company shares by insiders. This compares with the preceding 90-day window of time where there were 3 transactions from 3 insiders that resulted in the net disposition of 14,297 shares.
This level of insider transactions is lower than the peer group average in the 55-company Biopharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 46.9 transactions per company, with company insiders acquiring on average 136,607 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1293310/000138713121001789/xslF345X03/form4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.